Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
European Journal of Nuclear Medicine|January 1, 1990
In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTcM Ecclestone, A Proulx, J R Ballinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cellsJ R Ballinger, J Bannerman, I Boxen, et al.
Clinical Nuclear Medicine|August 1, 1994
Scintigraphic flare in skeletal lymphomaL M White, B G Gray, M Ichise, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1992
Technetium-99m-HMPAO SPECT in the evaluation of patients with a remote history of traumatic brain injury: a comparison with x-ray computed tomographyB G Gray, M Ichise, D G Chung, et al.
Bioconjugate Chemistry|September 30, 1999
Synthesis and evaluation of two technetium-99m-labeled peptidic 2-nitroimidazoles for imaging hypoxiaZ F Su, X Zhang, J R Ballinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1994
Technetium-99m-HMPAO SPECT, CT and MRI in the evaluation of patients with chronic traumatic brain injury: a correlation with neuropsychological performanceM Ichise, D G Chung, P Wang, et al.
Magnetic Resonance Imaging|January 1, 1995
P-31 changes as a measure of therapy response in resistant and sensitive osteosarcomas implanted into nude miceJ R Ballinger, H Kang, C A Sweeney, et al.
Annals of Nuclear Medicine|December 5, 1998
Characterization of neuronal damage by iomazenil binding and cerebral blood flow in an ischemic rat modelH Toyama, K Matsumura, H Nakashima, et al.
Pageof 12